Company Encyclopedia
View More
name
SUNHERE
300452.SZ
Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. research and development, production, and sale of new pharmaceutical excipients in China. The company provides cellulose, starch, povidone, stearic acid, coating powder, resin, food additive, and other products. It also exports its products.
3.159 T
300452.SZMarket value -Rank by Market Cap -/-

Financial Score

07/12/2025 Update
B
PharmaceuticalsIndustry
Industry Ranking71/223
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE13.84%B
    • Profit Margin13.86%B
    • Gross Margin30.95%C
  • Growth ScoreC
    • Revenue YoY10.85%B
    • Net Profit YoY-19.24%D
    • Total Assets YoY4.42%C
    • Net Assets YoY5.63%B
  • Cash ScoreB
    • Cash Flow Margin721.44%B
    • OCF YoY10.85%B
  • Operating ScoreB
    • Turnover0.59B
  • Debt ScoreB
    • Gearing Ratio36.45%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    SUNHERE released its performance for the first three quarters, with a net profit attributable to the parent company of 133 million yuan, an increase of 8.28%

    According to the Zhitong Finance APP, SUNHERE released its third-quarter report for 2025. The company's operating revenue for the first three quarters was 697 million yuan, a year-on-year increase of 8.09%. The net profit attributable to shareholders of the listed company was 133 million yuan, a year-on-year increase of 8.28%. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 120 million yuan, a year-on-year increase of 14.02%. The basic earnings per share were 0.57 yuan

    Zhitong·
    SZ
    300452
    0.00%
    Zhitong·
    SZ
    300452
    0.00%

    SUNHERE: The controlling shareholder and actual controller has changed from Yin Zhenglong to Wu Changhong

    SUNHERE announced that the controlling shareholder and actual controller has changed from Yin Zhenglong to Wu Changhong. After the passing of Yin Zhenglong, his wife Wu Changhong and daughter Yin Zhiya inherited the company's shares. Wu Changhong directly holds 20.172% of the shares, while Yin Zhiya holds 6.724% of the shares and has signed a "Voting Rights Delegation Agreement," entrusting all identity rights of her shares to Wu Changhong for exercise

    Zhitong·
    SZ
    300452
    0.00%
    Zhitong·
    SZ
    300452
    0.00%

    Anhui Sunhere Says Chairman Passed Away, Operations Will Not Be Affected

    Anhui Sunhere Pharmaceutical Excipients Co Ltd :SAYS CHAIRMAN YIN ZHENGLONG PASSED AWAY ON AUG. 26, OPERATIONS WILL NOT BE AFFECTED

    Reuters·
    SZ
    300452
    0.00%
    Reuters·
    SZ
    300452
    0.00%

    SUNHERE released its performance for the first half of the year, with a net profit attributable to the parent company of 93.0352 million yuan, a decrease of 2.61%

    According to the Zhitong Finance APP, SUNHERE released its semi-annual report for 2025, showing that the company's operating income was 471 million yuan, an increase of 4.65% year-on-year. The net profit attributable to shareholders of the listed company was 93.0352 million yuan, a decrease of 2.61% year-on-year. The net profit attributable to shareholders of the listed company after deducting non-recurring gains and losses was 84.754 million yuan, an increase of 6.05% year-on-year. The basic earnings per share were 0.4 yuan

    Zhitong·
    SZ
    300452
    0.00%
    Zhitong·
    SZ
    300452
    0.00%

    SUNHERE has added 1 new pharmaceutical excipient product

    According to the Zhitong Finance APP, SUNHERE announced that the company has added a new pharmaceutical excipient product: Mannitol pellet core has obtained the registration number from the National Medical Products Administration's Center for Drug Evaluation (referred to as "CDE"), which is F20250000241. Mannitol pellet core is a white or off-white spherical pellet made from D-mannitol and other excipients, primarily used as a carrier for enteric-coated micro-pellet formulations and sustained-release micro-pellet formulations, and can also be used directly as a drug micro-pellet

    Zhitong·
    SZ
    300452
    0.00%
    Zhitong·
    SZ
    300452
    0.00%
    © 2025 Longbridge｜Disclaimer